Abstract

BackgroundDifferent treatment options are available for the management of BPH. Our study aimed to compare the surgical outcomes of a holmium laser enucleation of the prostate (HoLEP) and a bipolar transurethral resection of the prostate (Bipolar-TURP) after 2 years.MethodsOur prospective randomized study included 114 patients: 55 patients underwent HoLEP procedure and 59 patients underwent bipolar TURP procedure. All patients underwent a complete preoperative assessment and a physical examination. The postoperative follow-up data included Q max and IPSS recordings at 1, 3, 6, 12, and 24 months and PVR urinary volume recordings at 6 and 12 months. Any postoperative complications were also recorded.ResultsThere were no statistically significant differences between both groups regarding IPSS and Q max scores at one and 24 months postoperative. Also, there were no statistically significant differences between both groups regarding postoperative PVR at 6 and 12 months. One patient in the HoLEP group developed total incontinence after surgery.ConclusionOur study did not show a significant difference between HoLEP and bipolar TURP regarding postoperative Q max and IPSS scores at 24 months of follow-up.

Highlights

  • Different treatment options are available for the management of Benign prostatic hyperplasia (BPH)

  • Over the past decade, consistent data have demonstrated the superiority of other means of surgical intervention, and bipolar Transurethral resection of prostate (TURP) and a holmium laser enucleation of the prostate (HoLEP) are considered well-established surgical treatments for BPH [3]

  • 7 Results No statistically significant differences existed between the two groups regarding the preoperative parameters (Table 1)

Read more

Summary

Introduction

Different treatment options are available for the management of BPH. Our study aimed to compare the surgical outcomes of a holmium laser enucleation of the prostate (HoLEP) and a bipolar transurethral resection of the prostate (Bipolar-TURP) after 2 years. Benign prostatic hyperplasia (BPH) is a common disease affecting men over the age of 60 years. While surgical management of BPH is always debatable, for many years, the monopolar transurethral resection of the prostate (monopolar-TURP) has been accepted as the gold standard to surgically alleviate obstructive voiding dysfunction in men with BPH [2]. Over the past decade, consistent data have demonstrated the superiority of other means of surgical intervention, and bipolar TURP and a holmium laser enucleation of the prostate (HoLEP) are considered well-established surgical treatments for BPH [3]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call